Skip to main content
AMCP Nexus 2024 Main banner
Back

Drugs, Diseases, and the Managed Care Impact

(D1) Identifying the Managed Care Impact of Bipolar Disorder: Treatment Advancements, Accurate Diagnosis, and Equitable Care

Tuesday, October 15, 2024
8:30 AM – 9:45 AM PT
Location: 121
CPE
ACPE UAN:0233-0000-24-040-L01-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
This activity is supported by an independent medical education grant from Intra-Cellular Therapies, Inc.

Bipolar disorders (BD) are debilitating mental health conditions impacting approximately 4.4% of the United States population and ranked among the top 10 conditions causing medical disability among individuals between the ages of 15 and 44, with a potential loss of approximately 10 to 20 years of life. Misdiagnosis continues to remain a prevalent issue, often leading to delayed or inappropriate treatment interventions by a mean of approximately 9 years from an initial depressive episode, exacerbating the disease severity and complicating management. Disparities continue to further complicate barriers to optimal care and add to the overall burden of mental health. Faculty for this session will focus on the latest advancements in bipolar disorder management to align managed care strategies that support accurate and timely diagnosis and bridge access and utilization of care for marginalized groups.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Identify the new and emerging treatment options for bipolar disorder, distinguishing clinical efficacy, safety, and FDA‐approved indications.
  2. Describe the impact of misdiagnosis and improper treatment of bipolar disorder from a managed care perspective.
  3. Recognize existing health disparities adding to the disease burden of bipolar disease.
  4. Discuss managed care formulary and drug utilization considerations to address barriers to timely and equitable care for bipolar disorder.